1. Souttar H.S. Radium and cancer. London : W. Heinemann, 1934.
2. Cleminson F.J., Monkhouse J.P. Carcinoma of the oesophagus treated by radiation // J. Laryngol. Otol. 1934. Vol. 49, N 5. P. 313–318.
3. New G.B., Kirch W., Erich J.B. Tumots of the nose and throat // Arch. Otolaryngol. Head Neck Surg. 1939. Vol. 30, N 2. P. 283–297.
4. Иванов С.М. Химиолучевая терапия рака пищевода // Практическая онкология. 2008. Т. 9, № 1. С.21–26.
5. Shridhar R., Almhanna K., Meredith K.L. et. al. Radiation therapy and esophageal cancer // Cancer Control. 2013. Vol. 20, N 2. P. 92–110.
6. Канаев С.В., Щербаков А.М., Тюряева Е.И., Аванесян А.А. Консервативное лечение местнораспространенного и неоперабельного рака пищевода: Возможности и перспективы // Вопросы онкологии. 2012. Т. 58, № 2. С. 199–202.
7. Muijs C.T., Beukema J.C., Mul V.E. et al. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma // Radiother. Oncol. 2012. Vol. 102, N 2. P. 303–308.
8. Киселева Е.С., Зимина Е.С. Рак пищевода. Лучевая терапия злокачественных опухолей / Под ред. Е.С. Киселевой. Москва : Медицина. 1996. С. 193–208.
9. Gagliardi G., Constine L.S., Moiseenko V. et al. Radiation dose-volume effects in the heart // Int. J. Radiat. Oncol. Biol. Phys. 2010. Vol. 76. P. 777–785.
10. Hiroyuki Kuwano, Yasumasa Nishimura, Tsuneo Oyama et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society // Esophagus. 2015. Vol. 12. P. 1–30.
11. Mukai M., Kubota S., Morita S., Akanuma A. A pilot study of combination therapy of radiation and local administration of OK-432 for esophageal cancer: five-year survival and local control rate // Cancer. 1995. Vol. 75. P. 2276–2280.
12. Деньгина Н.В. Современные терапевтические возможности при раке пищевода // Практическая онкология. 2012. Т. 13, № 4. С. 276–288.
13. Minsky B.D., Pajak T., Ginsberg R. et al. INT0123 (Radiation Therapy Oncology Group 94–05) phase III trial of combined-modality therapy for esophageal cancer high-dose versus standard dose radiation therapy // J. Clin. Oncol. 2002. Vol. 20. P. 1167–1174.
14. Тюряева Е.А., Канаев С.В. Химиолучевое лечение рака пищевода: результаты и ближайшие перспективы (обзор) // Вопросы онкологии. 2012. Т. 58, № 3. С. 312–319.
15. Coia L.R. Chemoradiation as primary management of esophageal cancer // Semin. Oncol. 1994. Vol. 21, N 4. P. 483–492.
16. Nemoto K., Matsumoto Y., Yamakawa M. et al. Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience // Int. J. Radiat. Oncol. Biol. Phys. 2000. Vol. 46, N 4. P. 921–925.
17. Sun X., Yu J., Fan X. et al. Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest // Zhonghua Zhong Liu Za Zhi. 2006. Vol. 28, N 10. P. 784–787.
18. Tanisada K., Teshima T., Ikeda H. et al. Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study // Radiat. Med. 1998. Vol. 16, N 6. P. 461–468.
19. Itoh Y., Fuwa N., Matsumoto A. et al. Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis // Radiat. Med. 2001. Vol. 19, N 5. P. 231–235.
20. Ложков А.А. Сочетанная лучевая терапия рака грудного отдела пищевода с применением брахитерапии высокой мощности: дис. ... канд. мед. наук. Москва, 2020. 134 с.
21. Perez A., Halperin E.C. Principles and practice of radiation oncology. Philadelphia : Wolters Kluwer, 2019. 7402 p.
22. Walterbos N.R., Fiocco M., Neelis K.J. et al. Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer // Clin. Transl. Radiat. Oncol. 2019. Vol. 24, № 17. P. 24–31.
23. Earlam R., Cunha-Melo J.R. Oesophogeal squamous cell carcinoma, II: a critical view of radiotherapy // Br. J. Surg. 1980. Vol. 67, N 7. P. 457–461.
24. Okawa T., Dokiya T., Nishio M. et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group // Int. J. Radiat. Oncol. Biol. Phys. 1999. Vol. 45, № 3. P. 623–628.
25. Давыдов М.И., Стилиди И.С. Рак пищевода. Москва : Издательская группа РОНЦ, Практическая медицина, 2007. 392 с.
26. Martin S., Chen J.Z., Rashid Dar A. et al. Dosimetric comparison of helical tomotherapy, RapidArc, and a novel IMRT & Arc technique for esophagealcarcinoma // Radiother. Oncol. 2011. Vol. 101, N 3. P. 431–437.
27. Kole T.P., Aghayere O., Kwah J. et al. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 83, N 5. P. 1580–1586.
28. Nicolini G., Ghosh-Laskar S., Shrivastava S.K. et al. Volumetric modulationarc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study // Int. J. Radiat. Oncol. Biol. Phys. 2012. Vol. 84, N 2. P. 553–560.
29. Welsh J., Gomez D., Palmer M.B. et al. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81, N 5. P. 1336–1342.
30. Борисов В.А., Шинкарев С.А., Ильин Н.В., Флоровская Н.А. Лучевая терапия рака пищевода на основе применения электромагнитной гипертермии // Медицинская радиология и радиационная безопасность. 2010. Т. 55. № 5. С. 31–34.